ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

January 17, 2021

Testosterone stimulates cholesterol clearance from human macrophages by activating LXRα

Life Sciences
Elizabeth L KilbyT Hugh Jones
January 21, 2021
Open Access

Interleukin 12p40 Deficiency Promotes Abdominal Aortic Aneurysm by Activating CCN2/MMP2 Pathways.

Journal of the American Heart Association
Neekun Sharma, Chetan P Hans
January 18, 2021
Open Access

PROXIMITY TO DEMENTIA ONSET AND MULTI-MODAL NEUROIMAGING CHANGES: THE PREVENT-DEMENTIA STUDY

NeuroImage
Elijah MakJohn T O'Brien
January 16, 2021
Open Access

The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change

NPJ Genomic Medicine
Akinyemi Oni-OrisanThomas J Hoffmann
January 16, 2021
Preprint
Open Access

Development of Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD)

MedRxiv : the Preprint Server for Health Sciences
S. A. BellTerry E. Goldberg
January 22, 2021

Harmine alleviates atherogenesis by inhibiting disturbed flow-mediated endothelial activation via PTPN14/YAP.

British Journal of Pharmacology
Yujie YangJinlong He
January 16, 2021

Platelet releasate normalises the compromised muscle regeneration in a mouse model of hyperlipidaemia

Experimental Physiology
Joseph BarlowAntonios Matsakas
January 19, 2021
Review
Open Access

Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review

Curēus
Mehak Agarwal, Safeera Khan
January 15, 2021
Preprint
Open Access

Lack of evidence for interactions between APOE and Klotho genotypes on cognitive, dementia and brain imaging metrics in UK Biobank

MedRxiv : the Preprint Server for Health Sciences
R. TankDonald M. Lyall
January 17, 2021
Open Access

Oral administration of MnCl2 attenuated hyperlipidemia-related cardiac remodeling in ApoE-/- mice

Journal of Pharmacological Sciences
Han-Xiao ZhangShu-Guang Yu
January 18, 2021

Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD

Journal of Clinical Lipidology
Eduardo Vilar-GomezNaga Chalasani
January 14, 2021
Preprint
Open Access

ApoE4 attenuates cortical neuronal activity and impairs memory in young apoE4 rats

BioRxiv : the Preprint Server for Biology
I. Har-PazAnan Moran

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2021 Meta ULC. All rights reserved
/feed-previews/apoe-phenotypes/5f08b7b2-e8f9-419f-ac8f-e19485a1800c